Stockscreener 앱 받기
1.49
2.05%
0.03
시간 외 거래:
1.52
0.03
+2.01%
전일 마감가:
$1.46
열려 있는:
$1.5
하루 거래량:
631.68K
Relative Volume:
0.79
시가총액:
$8.63M
수익:
-
순이익/손실:
$-16.76M
주가수익비율:
-18.62
EPS:
-0.08
순현금흐름:
$-132.97M
1주 성능:
-6.88%
1개월 성능:
-10.51%
6개월 성능:
-90.62%
1년 성능:
-92.38%
1일 변동 폭
$1.40
$1.51
1주일 범위
$1.40
$1.73
52주 변동 폭
$1.38
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
명칭
X 4 Pharmaceuticals Inc
전화
857-529-8300
주소
61 NORTH BEACON STREET, BOSTON, MA
XFOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
1.49 | 11.34M | 0 | -16.76M | -132.97M | -0.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-12 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 재개 | B. Riley Securities | Buy |
| 2022-12-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 개시 | Piper Sandler | Overweight |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | ROTH Capital | Buy |
| 2019-12-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-12-05 | 개시 | B. Riley FBR | Buy |
| 2019-06-07 | 개시 | Stifel | Buy |
| 2019-06-05 | 개시 | Cowen | Outperform |
모두보기
X 4 Pharmaceuticals Inc 주식(XFOR)의 최신 뉴스
Is X4 Pharmaceuticals Inc. building a consolidation baseBreakout Watcher with Entry and Exit Alerts - Newser
X4 Pharmaceuticals Inc. stock outlook for YEARAI Generated Buy/Sell Signal Forecast - Newser
What analysts say about X4 Pharmaceuticals Inc. stock outlookPredictable Return Plan with Entry Guidance - Newser
Regression analysis insights on X4 Pharmaceuticals Inc. performanceRisk Managed Watchlist with Breakout Picks - Newser
Does X4 Pharmaceuticals Inc. fit your quant trading modelBuy Candidate Summary Based on Fundamentals - Newser
Momentum divergence signals in X4 Pharmaceuticals Inc. chartSummary of Long-Term Buy Zone Stocks - Newser
Exit strategy if you’re trapped in X4 Pharmaceuticals Inc.Daily Stock Watch Summary with Key Insights - Newser
X4 Pharmaceuticals Inc. stock daily chart insights5-Year Price Trend Summary and Analysis - Newser
Real time alert setup for X4 Pharmaceuticals Inc. performanceStock Price Prediction Using AI Tools - Newser
Leading vs lagging indicators on X4 Pharmaceuticals Inc. performanceFree News Based Entry Opportunity Alerts - Newser
X4 Pharmaceuticals: Q2 Earnings Snapshot - San Francisco Chronicle
X4 Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
X4 Pharmaceuticals, Inc SEC 10-Q Report - TradingView
Combining price and volume data for X4 Pharmaceuticals Inc.Watchlist Generator With Real-Time Entry - Newser
Fierce Biotech Layoff Tracker 2025: Tune, Bicycle let go of 25% of staff - Fierce Biotech
How to integrate X4 Pharmaceuticals Inc. into portfolio analysis toolsWeekly Growth Portfolio Performance Summary - Newser
X4 Pharmaceuticals (XFOR) to Release Quarterly Earnings on Thursday - Defense World
What makes X4 Pharmaceuticals Inc. stock price move sharplyLong-Term Stock Growth Forecast Insights - Newser
How to use Fibonacci retracement on X4 Pharmaceuticals Inc.Smart Entry Watchlist with Daily Analysis - Newser
Layoff Tracker: Sirona Liquidates TFChem, Merck Will Cut 6,000 Employees - BioSpace
X4 Pharmaceuticals Inc expected to post a loss of $4.34 a shareEarnings Preview - TradingView
What analysts say about X4 Pharmaceuticals Inc. stockBuild wealth steadily with smart trading - Jammu Links News
What is X4 Pharmaceuticals Inc. company’s growth strategyFree Wealth Management Insights - Jammu Links News
What is the dividend policy of X4 Pharmaceuticals Inc. stockFree Wealth Planning Blueprint - Jammu Links News
Why X4 Pharmaceuticals Inc. stock attracts strong analyst attentionShort-Term Sector Movement Forecast Generator - Newser
When is X4 Pharmaceuticals Inc. stock expected to show significant growthHigh-profit capital plays - Jammu Links News
Is X4 Pharmaceuticals Inc. a growth stock or a value stockSkyrocketing returns - Jammu Links News
What catalysts could drive X4 Pharmaceuticals Inc. stock higher in 2025Build a portfolio that outperforms the market - Jammu Links News
What are the latest earnings results for X4 Pharmaceuticals Inc.Get real-time alerts on top stocks - Jammu Links News
How does X4 Pharmaceuticals Inc. compare to its industry peersGet expert advice on portfolio optimization - Jammu Links News
X4 Pharmaceuticals Inc. Stock Analysis and ForecastHarness the power of proven investment plans - Jammu Links News
What are analysts’ price targets for X4 Pharmaceuticals Inc. in the next 12 monthsUnlock powerful trading signals for profits - Jammu Links News
Is X4 Pharmaceuticals Inc. stock overvalued or undervaluedFree Technical Analysis Support - Jammu Links News
Measuring X4 Pharmaceuticals Inc.’s beta against major indicesIntelligent Trade Forecast With AI Analytics - Newser
Strategies to average down on X4 Pharmaceuticals Inc.Volume Based Swing Signal Prediction Map - Newser
X 4 Pharmaceuticals Inc (XFOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):